Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70262
Authors: Rui Sun, Ying Wang, Hongyan Shu, Li Li, Jianping Yao, Xiuhai Su, Bimin Shi, Chaoming Wu, Jianhua Ma, Qinghua Wang
Institutions: Nanjing First Hospital, Nanjing Medical University, Central Hospital of Zibo, Ningbo University, Huzhou Normal University, Huzhou Central Hospital, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province, First Affiliated Hospital of Soochow University, Wenzhou Medical University, Shanghai Medical College of Fudan University, Fudan University, Huashan Hospital, Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (China)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416066062